SAN DIEGO, April 28, 2017 /PRNewswire/ — Epic Sciences (Epic) announced today that the company has completed a $40 million Series D financing led by Hermed Capital. Altos Capital Partners, Domain Associates, Genomic Health, Pagoda Investment, Reach Tone Limited, RMI Partners, Sabby…
April 28, 2017 at 04:48PM
from
No comments:
Post a Comment